Articles from Biotech Business (June 1, 2008)

1-4 out of 4 article(s)

Title	Author	Type	Words
DUSKA THERAPEUTICS PLANS NDA 505(B)(2) FILING FOR ATPACE.			512
FDA PROVIDES CLARITY TO ISIS ON MIPOMERSEN REQUIREMENTS.			866
METABASIS GETS GOOD RESULTS FROM MB07803 PHASE 2A TRIAL.			861
MOLECULAR INSIGHT INITIATES PHASE 2A AZEDRA CLINICAL TRIAL.			1058

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	before 1995 1995-1999 2000-2004 2005-2009 2010-	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z